UnitedHealth Group (NYSE:UNH) Issues FY 2025 Earnings Guidance

Key Points

• UnitedHealth Group issued FY 2025 earnings guidance with an expected EPS of 16.000-, slightly below the consensus estimate of 16.230.
• The company recently reported a quarterly EPS of $4.08, missing the consensus estimate by ($0.37), with quarterly revenue rising 12.9% year-over-year.
• Several analysts have lowered their price targets for UnitedHealth Group, with Piper Sandler reducing it from $353.00 to $317.00.

UnitedHealth Group (NYSE:UNH - Get Free Report) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 16.000- for the period, compared to the consensus estimate of 16.230. The company issued revenue guidance of -.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $339.57 on Wednesday. UnitedHealth Group has a one year low of $234.60 and a one year high of $630.73. The stock has a market cap of $307.54 billion, a P/E ratio of 14.71, a P/E/G ratio of 2.27 and a beta of 0.45. The company has a fifty day moving average price of $293.51 and a two-hundred day moving average price of $367.23. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same period in the prior year, the business earned $6.80 earnings per share. UnitedHealth Group's quarterly revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities analysts predict that UnitedHealth Group will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be given a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.6%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's dividend payout ratio is 38.30%.

Analysts Set New Price Targets

Several research firms have recently issued reports on UNH. Piper Sandler lowered their price target on UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating for the company in a research report on Wednesday, July 30th. HSBC reissued a "reduce" rating and issued a $270.00 price objective (down from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. JPMorgan Chase & Co. reduced their target price on UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating on the stock in a research report on Wednesday, August 6th. Bank of America upped their price objective on UnitedHealth Group from $290.00 to $325.00 and gave the stock a "neutral" rating in a research report on Monday, August 18th. Finally, Baird R W lowered UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research report on Thursday, July 31st. Sixteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $358.95.

Hedge Funds Weigh In On UnitedHealth Group

Large investors have recently added to or reduced their stakes in the company. Lone Pine Capital LLC bought a new position in UnitedHealth Group during the second quarter valued at $528,273,000. CANADA LIFE ASSURANCE Co lifted its position in shares of UnitedHealth Group by 7.1% during the second quarter. CANADA LIFE ASSURANCE Co now owns 1,189,542 shares of the healthcare conglomerate's stock valued at $371,503,000 after buying an additional 79,311 shares during the last quarter. Orbis Allan Gray Ltd lifted its position in shares of UnitedHealth Group by 63.4% during the second quarter. Orbis Allan Gray Ltd now owns 1,086,717 shares of the healthcare conglomerate's stock valued at $339,023,000 after buying an additional 421,575 shares during the last quarter. Route One Investment Company L.P. increased its holdings in shares of UnitedHealth Group by 8.0% during the second quarter. Route One Investment Company L.P. now owns 470,300 shares of the healthcare conglomerate's stock valued at $146,719,000 after acquiring an additional 34,700 shares in the last quarter. Finally, State of Tennessee Department of Treasury increased its holdings in shares of UnitedHealth Group by 4.4% during the second quarter. State of Tennessee Department of Treasury now owns 340,735 shares of the healthcare conglomerate's stock valued at $106,299,000 after acquiring an additional 14,425 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.